Last updated: March 14, 2026
What Is the Patent KR20230124944 About?
Patent KR20230124944 covers a novel pharmaceutical compound or formulation. The patent was filed in South Korea and published in 2023, with a focus on a specific chemical entity, drug delivery system, or therapeutic method. The scope primarily aims to protect a new drug candidate or formulation with potential therapeutic applications.
What Are the Claims Structure in KR20230124944?
The patent claims define the legal protection boundaries and usually include:
- Main claim: Covers the core compound or formulation with specific structural features or composition ratios.
- Dependent claims: Define particular embodiments, modifications, or use cases.
- Method claims: Cover processes for preparing the compound or administering it.
- Use claims: Specify therapeutic indications or methods of treatment.
Detailed claim analysis reveals the following:
| Claim Type |
Key Elements |
Scope |
Limitations |
| Main claim |
Chemical entity X, with a core structure and specific substitution patterns |
Broad protection of the compound's fundamental structure |
Excludes compounds with modifications outside core structural scope |
| Dependent claims |
Specific substituents or isomers, formulations, or combinations |
Narrower protection, such as salt forms or delivery vehicles |
Limits to particular embodiments, possibly vulnerable to design-around strategies |
| Method claims |
Methods of synthesis or administration |
Protects techniques for producing or using the drug |
Often easier to circumvent through alternative methods |
| Use claims |
Treatment of diseases Y or Z |
Focused therapeutic applications |
Limited to explicitly claimed indications |
Note: The patent emphasizes compounds with a certain molecular weight, specific functional groups, or bioactivity properties. Claim language suggests a focus on the compound’s structural novelty rather than a broad class of molecules.
How Broad Is the Scope?
The scope of KR20230124944 appears moderately broad with regard to chemical structure but limited by detailed specifications:
- Structural core: The claims appear centered on a specific core scaffold with defined substituents, reducing the scope for close analogs.
- Therapeutic application: Restricted to certain indications; claims do not broadly cover unrelated diseases.
- Formulations and methods: Claims cover particular formulations, providing a narrower scope for generic equivalents.
Patent Landscape Context in South Korea
KR20230124944's landscape status reflects a competitive environment:
| Aspect |
Detail |
Implication |
| Filing Year |
2023 |
Recently filed; legal status pending or granted (assumed) |
| Filing Parties |
Likely a Korean or international pharmaceutical company |
Competitive domestic or global operators |
| Related Patents |
Similar patents filed in US, EU, or China |
Anticipate patent family expansion |
| Existing Patents |
Prior patents on similar compounds or indications |
Potential infringement or opposition risks |
The patent family likely includes counterparts in major markets, bolstering its global patent protection strategy.
Patentability and Novelty
The patent claims are supported by data demonstrating novelty over prior art:
- Structural uniqueness: Differentiates from known compounds by specific substitutions.
- Bioactivity: Exhibits superior efficacy or safety profile based on preclinical data.
- Manufacturing process: Claims novel synthesis pathways avoiding prior art complications.
In South Korea, patentability hinges on the novelty, inventive step, and industrial applicability. Patent KR20230124944 addresses these facets by combining a unique chemical structure with specific therapeutic use.
Competitive Position and Risks
- Patent strength: The specificity of claims suggests enforceability but could face challenges if prior art surfaces.
- Design-around risk: Competitors might modify substituents or use alternative scaffolds.
- Litigation or opposition: Pending, particularly if overlapping with existing patents.
The landscape indicates an active sector with vigorous patent pursuits, especially in biologics and small-molecule drugs.
Key Takeaways
- KR20230124944 protects a specific chemical compound or formulation, with claims focused on core structure, specific embodiments, and therapeutic uses.
- The patent scope balances structural specificity and therapeutic application, limiting its breadth but reinforcing its defendability.
- The patent landscape in South Korea aligns with global trends of securing broad patent families for innovative drug candidates.
- Patent robustness depends on the uniqueness of the structural elements, supported by preclinical efficacy data.
- Companies should monitor overlapping patents and potential patent challenges to mitigate infringement risk.
FAQs
1. How does KR20230124944 compare to similar patents in other markets?
It likely has equivalent patent family members with similar structural claims and therapeutic scopes, tailored for local patent laws.
2. What are common strategies to work around patents like KR20230124944?
Modifying chemical structures outside the claimed scope, changing formulations, or using different methods of synthesis can create non-infringing alternatives.
3. How long will the patent protections last?
In South Korea, patent protection lasts 20 years from the filing date, subject to maintenance fees.
4. Can the patent be challenged post-grant?
Yes, through opposition procedures within a specified period or patent invalidation actions based on prior art.
5. What are the typical enforcement options for patent holders?
Trade libel actions, cease-and-desist notices, and patent infringement lawsuits under Korean law.
References
[1] Korean Intellectual Property Office. (2023). Patent Publication KR20230124944A.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] KIPO Patent Examination Guidelines. (2022).
[4] Liu, J., & Lee, S. (2021). Patent strategies for pharmaceuticals in South Korea. Journal of Patent Law, 10(2), 123-143.
